USFDA issues import alert for Ranbaxy Mohali facilities

In a major blow to Ranbaxy Laboratories, USFDA has imposed a ban against its Mohali facilities. This ban is likely to impact Ranbaxy's export plans. Mint's CH Unnikrishnan has more on this